ECMO Market to 2027 - Global Analysis and Forecasts by Method (Venoarterial ECMO, Venovenous ECMO and Arteriovenous ECMO), By Application (Cardiology, Respiratory, and Others)
Report Code: TIPHE100001219 No. of Pages: 150 Category: Medical Device Status: Upcoming
ECMO (Extracorporeal membrane oxygenation) is a treatment used for the circulation of blood through an artificial lung back into the bloodstream of a very sick baby. The system enables to provide heart-lung bypass route outside of the baby's body. This may provide help to support a child who need a heart or lung transplant. The main purpose of ECMO is to provide oxygen to the baby whose heart and lungs to heal or rest.
The market for the ECMO is driving due to the key factors such as rise in the number of heart and lung transplants, rise in the number of infants with the heart problem, rise in the number of patients with the breathing. In addition, to this the growing cases of the cardiovascular diseases and rising awareness among the people for heart and lung transplants. The populous regions have wide scope of opportunities for the players to produce more ECMO products as the rise in the growing geriatric population suffers from the cardiopulmonary diseases.
The "Global ECMO Market Analysis to 2027" is a specialized and in-depth study of the ECMO industry with a focus on the global market trend. The report aims to provide an overview of global ECMO market with detailed market segmentation by method, application and geography. The global ECMO market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The ECMO market is segmented based on method and application. The method segment include venoarterial ECMO, venovenous ECMO, and arteriovenous ECMO. The application segment is classified as cardiology, respiratory and others.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global ECMO market based on type and application. It also provides market size and forecast till 2027 for overall ECMO market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to hold largest share of the ECMO market, followed by Europe. Asia Pacific are expected to grow at a fast rate during the analysis period, as the rise in the number of cardiovascular diseases, increase in birth defects of the heart, severe pneumonia and high blood pressure in the arteries of the lungs are leading to the growth of market across the world. In addition to this the reimbursement plans and the expenditures for the healthcare industries are growing the market. These factors widening the growth opportunities for the players and are likely to propel the growth of market in future.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key ECMO companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are TERUMO CORPORATION, Medtronic, MicroPort Scientific Corporation, ALung Technologies, Inc., NIPRO, EUROSETS, MAQUET Holding B.V. & Co. KG., LivaNova PLC, OriGen Biomedical, and XENIOS AG.
The market for the ECMO is driving due to the key factors such as rise in the number of heart and lung transplants, rise in the number of infants with the heart problem, rise in the number of patients with the breathing. In addition, to this the growing cases of the cardiovascular diseases and rising awareness among the people for heart and lung transplants. The populous regions have wide scope of opportunities for the players to produce more ECMO products as the rise in the growing geriatric population suffers from the cardiopulmonary diseases.
The "Global ECMO Market Analysis to 2027" is a specialized and in-depth study of the ECMO industry with a focus on the global market trend. The report aims to provide an overview of global ECMO market with detailed market segmentation by method, application and geography. The global ECMO market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The ECMO market is segmented based on method and application. The method segment include venoarterial ECMO, venovenous ECMO, and arteriovenous ECMO. The application segment is classified as cardiology, respiratory and others.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global ECMO market based on type and application. It also provides market size and forecast till 2027 for overall ECMO market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to hold largest share of the ECMO market, followed by Europe. Asia Pacific are expected to grow at a fast rate during the analysis period, as the rise in the number of cardiovascular diseases, increase in birth defects of the heart, severe pneumonia and high blood pressure in the arteries of the lungs are leading to the growth of market across the world. In addition to this the reimbursement plans and the expenditures for the healthcare industries are growing the market. These factors widening the growth opportunities for the players and are likely to propel the growth of market in future.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key ECMO companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are TERUMO CORPORATION, Medtronic, MicroPort Scientific Corporation, ALung Technologies, Inc., NIPRO, EUROSETS, MAQUET Holding B.V. & Co. KG., LivaNova PLC, OriGen Biomedical, and XENIOS AG.
1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance
2 Key Takeaways
3 ECMO Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 ECMO - By Method
3.2.2 ECMO - By Application
3.2.3 Pain Management Devices - By Region
3.2.3.1 By Country
3.3 PEST Analysis
3.3.1 North America - PEST Analysis
3.3.2 Europe - PEST Analysis
3.3.3 Asia Pacific - PEST Analysis
3.3.4 Middle East and Africa - PEST Analysis
3.3.5 South and Central America- PEST Analysis
4 ECMO - Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis
5 ECMO - Global Analysis
5.1 Global ECMO Overview
5.2 Global ECMO Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Expert Opinions
6 ECMO- Global Regulatory Scenario
6.1 Overview
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Middle East & Africa
6.6 South and Central America
7 ECMO Revenue and Forecasts to 2027 - By Method
7.1 Overview
7.2 Method Market Revenue and Forecasts Analysis (US$ Mn)
7.3 Venoarterial ECMO Market
7.3.1 Overview
7.3.2 Venoarterial ECMO Market Revenue Forecasts and Analysis (US$ Mn)
7.4 Venovenous ECMO Market
7.4.1 Overview
7.4.2 Venovenous ECMO Market Revenue Forecasts and Analysis (US$ Mn)
7.5 Arteriovenous ECMO Market
7.5.1 Overview
7.5.2 Arteriovenous Market Revenue Forecasts and Analysis (US$ Mn)
8 ECMO Revenue and Forecasts to 2027 - By Application
8.1 Overview
8.2 Application Market Forecasts and Analysis
8.3 Cardiology Market
8.3.1 Overview
8.3.2 Cardiology Market Revenue Forecasts and Analysis (US$ Mn)
8.4 Respiratory Market
8.4.1 Overview
8.4.2 Respiratory Market Revenue Forecasts and Analysis (US$ Mn)
8.5 Others Market
8.5.1 Overview
8.5.2 Others Market Revenue Forecasts and Analysis (US$ Mn)
9 North America ECMO Revenue and Forecasts to 2027 - Country Analysis
9.1 North America ECMO Overview
9.2 North America ECMO Revenue Forecasts and Analysis (US$ Mn)
9.3 North America ECMO Revenue and Forecasts Analysis - By Method (US$ Mn)
9.4 North America ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
9.5 North America ECMO Revenue Forecasts and Analysis - By Country
9.6 US Market Overview
9.6.1 US ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
9.6.2 US ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7 Canada Market Overview
9.7.1 Canada ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
9.7.2 Canada ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
9.8 Mexico Market Overview
9.8.1 Mexico ECMO Revenue Forecasts and Analysis-By Method (US$ Mn)
9.8.2 Mexico ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
10 Europe ECMO Revenue and Forecasts to 2027 - Country Analysis
10.1 Europe ECMO Overview
10.2 Europe ECMO Revenue Forecasts and Analysis (US$ Mn)
10.3 Europe ECMO Revenue and Forecasts Analysis - By Method (US$ Mn)
10.4 Europe ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
10.5 Europe ECMO Revenue Forecasts and Analysis - By Country
10.6 UK Market Overview
10.6.1 UK ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
10.6.2 UK ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7 Germany Market Overview
10.7.1 Germany ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
10.7.2 Germany ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
10.8 France Market Overview
10.8.1 France ECMO Revenue Forecasts and Analysis-By Method (US$ Mn)
10.8.2 France ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
11 Asia Pacific ECMO Revenue and Forecasts to 2027 - Country Analysis
11.1 Asia Pacific ECMO Overview
11.2 Asia Pacific ECMO Revenue Forecasts and Analysis (US$ Mn)
11.3 Asia Pacific ECMO Revenue and Forecasts Analysis - By Method (US$ Mn)
11.4 Asia Pacific ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
11.5 Asia Pacific ECMO Revenue Forecasts and Analysis - By Country
11.6 Japan Market Overview
11.6.1 Japan ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
11.6.2 Japan ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7 China Market Overview
11.7.1 China ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
11.7.2 China ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
11.8 India Market Overview
11.8.1 India ECMO Revenue Forecasts and Analysis-By Method (US$ Mn)
11.8.2 India ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
12 Middle East and Africa (MEA) ECMO Revenue and Forecasts to 2027 - Country Analysis
12.1 Middle East & Africa ECMO Overview
12.2 Middle East & Africa ECMO Revenue Forecasts and Analysis (US$ Mn)
12.3 Middle East & Africa ECMO Revenue and Forecasts Analysis - By Method (US$ Mn)
12.4 Middle East & Africa ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
12.5 Middle East & Africa ECMO Revenue Forecasts and Analysis - By Country
12.6 South Africa Market Overview
12.6.1 South Africa ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
12.6.2 South Africa ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
12.7 Saudi Arabia Market Overview
12.7.1 Saudi Arabia ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
12.7.2 Saudi Arabia ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
12.8 UAE Market Overview
12.8.1 UAE ECMO Revenue Forecasts and Analysis-By Method (US$ Mn)
12.8.2 UAE ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
13 South and Central America ECMO Revenue and Forecasts to 2027 - Country Analysis
13.1 Middle East & Africa ECMO Overview
13.2 Middle East & Africa ECMO Revenue Forecasts and Analysis (US$ Mn)
13.3 Middle East & Africa ECMO Revenue and Forecasts Analysis - By Method (US$ Mn)
13.4 Middle East & Africa ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
13.5 Middle East & Africa ECMO Revenue Forecasts and Analysis - By Country
13.6 Brazil Market Overview
13.6.1 Brazil ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
13.6.2 Brazil ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
14 Industry Landscape
14.1 Organic Growth Strategies
14.1.1 New Product Launches
14.1.2 Marketing & Promotional Activities
14.2 Inorganic Growth Strategies
14.2.1 Partnerships, Collaborations, and Joint Ventures
14.2.2 Mergers & Acquisitions
15 ECMO, Key Company Profiles
15.1 TERUMO CORPORATION
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Financial Overview
15.1.4 Product Portfolio
15.1.5 Product Pipeline
15.1.6 SWOT Analysis
15.1.7 Key Developments
15.2 Medtronic
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Financial Overview
15.2.4 Product Portfolio
15.2.5 Product Pipeline
15.2.6 SWOT Analysis
15.2.7 Key Developments
15.3 MicroPort Scientific Corporation
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Financial Overview
15.3.4 Product Portfolio
15.3.5 Product Portfolio
15.3.6 SWOT Analysis
15.3.7 Key Developments
15.4 ALung Technologies, Inc.
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Financial Overview
15.4.4 Product Portfolio
15.4.5 Product Pipeline
15.4.6 SWOT Analysis
15.4.7 Key Developments
15.5 NIPRO
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Financial Overview
15.5.4 Product Portfolio
15.5.5 Product Portfolio
15.5.6 SWOT Analysis
15.5.7 Key Developments
15.6 EUROSETS
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Financial Overview
15.6.4 Product Portfolio
15.6.5 Product Pipeline
15.6.6 SWOT Analysis
15.6.7 Key Developments
15.7 MAQUET Holding B.V. & Co. KG.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Financial Overview
15.7.4 Product Portfolio
15.7.5 Product Pipeline
15.7.6 SWOT Analysis
15.7.7 Key Developments
15.8 LivaNova PLC
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Financial Overview
15.8.4 Product Portfolio
15.8.5 Product Pipeline
15.8.6 SWOT Analysis
15.8.7 Key Developments
15.9 OriGen Biomedical
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Financial Overview
15.9.4 Product Portfolio
15.9.5 Product Pipeline
15.9.6 SWOT Analysis
15.9.7 Key Developments
15.10 XENIOS AG
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Financial Overview
15.10.4 Product Portfolio
15.10.5 Product Pipeline
15.10.6 SWOT Analysis
15.10.7 Key Developments
16 Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
16.3 Research Methodology
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance
2 Key Takeaways
3 ECMO Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 ECMO - By Method
3.2.2 ECMO - By Application
3.2.3 Pain Management Devices - By Region
3.2.3.1 By Country
3.3 PEST Analysis
3.3.1 North America - PEST Analysis
3.3.2 Europe - PEST Analysis
3.3.3 Asia Pacific - PEST Analysis
3.3.4 Middle East and Africa - PEST Analysis
3.3.5 South and Central America- PEST Analysis
4 ECMO - Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis
5 ECMO - Global Analysis
5.1 Global ECMO Overview
5.2 Global ECMO Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Expert Opinions
6 ECMO- Global Regulatory Scenario
6.1 Overview
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Middle East & Africa
6.6 South and Central America
7 ECMO Revenue and Forecasts to 2027 - By Method
7.1 Overview
7.2 Method Market Revenue and Forecasts Analysis (US$ Mn)
7.3 Venoarterial ECMO Market
7.3.1 Overview
7.3.2 Venoarterial ECMO Market Revenue Forecasts and Analysis (US$ Mn)
7.4 Venovenous ECMO Market
7.4.1 Overview
7.4.2 Venovenous ECMO Market Revenue Forecasts and Analysis (US$ Mn)
7.5 Arteriovenous ECMO Market
7.5.1 Overview
7.5.2 Arteriovenous Market Revenue Forecasts and Analysis (US$ Mn)
8 ECMO Revenue and Forecasts to 2027 - By Application
8.1 Overview
8.2 Application Market Forecasts and Analysis
8.3 Cardiology Market
8.3.1 Overview
8.3.2 Cardiology Market Revenue Forecasts and Analysis (US$ Mn)
8.4 Respiratory Market
8.4.1 Overview
8.4.2 Respiratory Market Revenue Forecasts and Analysis (US$ Mn)
8.5 Others Market
8.5.1 Overview
8.5.2 Others Market Revenue Forecasts and Analysis (US$ Mn)
9 North America ECMO Revenue and Forecasts to 2027 - Country Analysis
9.1 North America ECMO Overview
9.2 North America ECMO Revenue Forecasts and Analysis (US$ Mn)
9.3 North America ECMO Revenue and Forecasts Analysis - By Method (US$ Mn)
9.4 North America ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
9.5 North America ECMO Revenue Forecasts and Analysis - By Country
9.6 US Market Overview
9.6.1 US ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
9.6.2 US ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7 Canada Market Overview
9.7.1 Canada ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
9.7.2 Canada ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
9.8 Mexico Market Overview
9.8.1 Mexico ECMO Revenue Forecasts and Analysis-By Method (US$ Mn)
9.8.2 Mexico ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
10 Europe ECMO Revenue and Forecasts to 2027 - Country Analysis
10.1 Europe ECMO Overview
10.2 Europe ECMO Revenue Forecasts and Analysis (US$ Mn)
10.3 Europe ECMO Revenue and Forecasts Analysis - By Method (US$ Mn)
10.4 Europe ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
10.5 Europe ECMO Revenue Forecasts and Analysis - By Country
10.6 UK Market Overview
10.6.1 UK ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
10.6.2 UK ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7 Germany Market Overview
10.7.1 Germany ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
10.7.2 Germany ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
10.8 France Market Overview
10.8.1 France ECMO Revenue Forecasts and Analysis-By Method (US$ Mn)
10.8.2 France ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
11 Asia Pacific ECMO Revenue and Forecasts to 2027 - Country Analysis
11.1 Asia Pacific ECMO Overview
11.2 Asia Pacific ECMO Revenue Forecasts and Analysis (US$ Mn)
11.3 Asia Pacific ECMO Revenue and Forecasts Analysis - By Method (US$ Mn)
11.4 Asia Pacific ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
11.5 Asia Pacific ECMO Revenue Forecasts and Analysis - By Country
11.6 Japan Market Overview
11.6.1 Japan ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
11.6.2 Japan ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7 China Market Overview
11.7.1 China ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
11.7.2 China ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
11.8 India Market Overview
11.8.1 India ECMO Revenue Forecasts and Analysis-By Method (US$ Mn)
11.8.2 India ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
12 Middle East and Africa (MEA) ECMO Revenue and Forecasts to 2027 - Country Analysis
12.1 Middle East & Africa ECMO Overview
12.2 Middle East & Africa ECMO Revenue Forecasts and Analysis (US$ Mn)
12.3 Middle East & Africa ECMO Revenue and Forecasts Analysis - By Method (US$ Mn)
12.4 Middle East & Africa ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
12.5 Middle East & Africa ECMO Revenue Forecasts and Analysis - By Country
12.6 South Africa Market Overview
12.6.1 South Africa ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
12.6.2 South Africa ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
12.7 Saudi Arabia Market Overview
12.7.1 Saudi Arabia ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
12.7.2 Saudi Arabia ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
12.8 UAE Market Overview
12.8.1 UAE ECMO Revenue Forecasts and Analysis-By Method (US$ Mn)
12.8.2 UAE ECMO Revenue Forecasts and Analysis-By Application (US$ Mn)
13 South and Central America ECMO Revenue and Forecasts to 2027 - Country Analysis
13.1 Middle East & Africa ECMO Overview
13.2 Middle East & Africa ECMO Revenue Forecasts and Analysis (US$ Mn)
13.3 Middle East & Africa ECMO Revenue and Forecasts Analysis - By Method (US$ Mn)
13.4 Middle East & Africa ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
13.5 Middle East & Africa ECMO Revenue Forecasts and Analysis - By Country
13.6 Brazil Market Overview
13.6.1 Brazil ECMO Revenue Forecasts and Analysis - By Method (US$ Mn)
13.6.2 Brazil ECMO Revenue Forecasts and Analysis - By Application (US$ Mn)
14 Industry Landscape
14.1 Organic Growth Strategies
14.1.1 New Product Launches
14.1.2 Marketing & Promotional Activities
14.2 Inorganic Growth Strategies
14.2.1 Partnerships, Collaborations, and Joint Ventures
14.2.2 Mergers & Acquisitions
15 ECMO, Key Company Profiles
15.1 TERUMO CORPORATION
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Financial Overview
15.1.4 Product Portfolio
15.1.5 Product Pipeline
15.1.6 SWOT Analysis
15.1.7 Key Developments
15.2 Medtronic
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Financial Overview
15.2.4 Product Portfolio
15.2.5 Product Pipeline
15.2.6 SWOT Analysis
15.2.7 Key Developments
15.3 MicroPort Scientific Corporation
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Financial Overview
15.3.4 Product Portfolio
15.3.5 Product Portfolio
15.3.6 SWOT Analysis
15.3.7 Key Developments
15.4 ALung Technologies, Inc.
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Financial Overview
15.4.4 Product Portfolio
15.4.5 Product Pipeline
15.4.6 SWOT Analysis
15.4.7 Key Developments
15.5 NIPRO
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Financial Overview
15.5.4 Product Portfolio
15.5.5 Product Portfolio
15.5.6 SWOT Analysis
15.5.7 Key Developments
15.6 EUROSETS
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Financial Overview
15.6.4 Product Portfolio
15.6.5 Product Pipeline
15.6.6 SWOT Analysis
15.6.7 Key Developments
15.7 MAQUET Holding B.V. & Co. KG.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Financial Overview
15.7.4 Product Portfolio
15.7.5 Product Pipeline
15.7.6 SWOT Analysis
15.7.7 Key Developments
15.8 LivaNova PLC
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Financial Overview
15.8.4 Product Portfolio
15.8.5 Product Pipeline
15.8.6 SWOT Analysis
15.8.7 Key Developments
15.9 OriGen Biomedical
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Financial Overview
15.9.4 Product Portfolio
15.9.5 Product Pipeline
15.9.6 SWOT Analysis
15.9.7 Key Developments
15.10 XENIOS AG
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Financial Overview
15.10.4 Product Portfolio
15.10.5 Product Pipeline
15.10.6 SWOT Analysis
15.10.7 Key Developments
16 Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
16.3 Research Methodology
The List of Companies
1. TERUMO CORPORATION
2. Medtronic
3. MicroPort Scientific Corporation
4. ALung Technologies, Inc.
5. NIPRO
6. EUROSETS
7. MAQUET Holding B.V. & Co. KG.
8. LivaNova PLC
9. OriGen Biomedical
10. XENIOS AG
1. TERUMO CORPORATION
2. Medtronic
3. MicroPort Scientific Corporation
4. ALung Technologies, Inc.
5. NIPRO
6. EUROSETS
7. MAQUET Holding B.V. & Co. KG.
8. LivaNova PLC
9. OriGen Biomedical
10. XENIOS AG